Pearce proposes lessening restrictions on drug access while increasing transparency and democratizing governance, on the grounds that this would both respect autonomy and rebalance risk-related tradeoffs to a more socially optimal position. I raise some questions about whether, and in what respects, democratization is the answer to these problems.
GianellaS.TaylorJ.BrownT. R.KaytesA.AchimC. L.MooreD. J.LittleS. J.EllisR. J.SmithD. M. (2017). Can research at the end of life be a useful tool to advance HIV cure?Aids (London, England), 31(1), 1. https://doi.org/10.1097/QAD.0000000000001300
MillerF. G.WertheimerA. (2007). Facing up to paternalism in research ethics. The Hastings Center Report, 37(3), 24–34. https://doi.org/10.1353/hcr.2007.0044
5.
PearceJ. M. (2026). Ethics as if your life depended on it. Journal of Empirical Research on Human Research Ethics, 15562646261453477. https://doi.org/10.1177/15562646261453477
6.
RhodesR.OstertagG. (2026). Does public engagement have a role in biomedical clinical research?Bioethics, 1–10. Advance online publication. https://doi.org/10.1111/bioe.70123
SteelR. (2026). Why engage communities in biomedical research? [manuscript submitted for publication]. Clinical Center Department of Bioethics, US NIH.